Louisiana

The Department of Health issued two final rules effective May 20, 2019.

• Final rule revising standards for the Pharmacy Benefits Management Program. The rule reinstates federal upper payment limits and conforms the reimbursement methodology for physician-administered drugs in a physician office setting with a CMS-approved state plan amendment.
• Final rule adding numerous diseases to the list of mandatory disease reporting requirements, and a requirement for children to receive meningococcal vaccinations in accordance with the Advisory Committee on Immunization Practice of the United States Public Health Service.

Also in Louisiana… Prior to adjourning on June 6, the legislature approved HR 257, a resolution by Rep. Frank Hoffmann (R) urging the Department of Health to pursue value-based payments in Medicaid to increase access to buprenorphine/naloxone and naltrexone products for opioid use disorder treatment.

For more information, contact NACDS’ Mary Staples at 817-442-1155.